Upfront tandem autologous non-myeloablative allogeneic stem cell transplant in high-risk multiple myeloma: a long-term single-centre experience

被引：1
|
作者：
Nguyen, Phillip C. [1 ]
Muirhead, Jenny [1 ]
Tan, Joanne [1 ]
Kalff, Anna [1 ,2 ]
Bergin, Krystal [1 ,2 ]
Walker, Patricia [1 ]
Spencer, Andrew [1 ,2 ]
机构：
[1] Monash Univ, Alfred Hlth, Dept Clin Haematol, Melbourne, Vic, Australia
[2] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2022年 / 52卷 / 07期
关键词：
multiple myeloma; transplant; high risk; allogeneic; CYTOGENETICS; CONSENSUS; IFM99-03; STANDARD; OUTCOMES;
D O I：
10.1111/imj.15842
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The role of upfront non-myeloablative allogeneic stem cell transplantation (NMA alloSCT) in high-risk multiple myeloma (HR-MM) is unclear. We evaluated outcomes of NMA alloSCT following autologous stem cell transplant (ASCT) compared with ASCT alone for newly diagnosed HR-MM. Two-year progression-free survival was improved in the ASCT-NMA alloSCT group (44% vs 16%; P = 0.035), with a trend for improved overall survival (P = 0.118). These results suggest that ASCT-NMA alloSCT can be considered as upfront therapy in HR-MM.
引用
收藏
页码：1263 / 1267
页数：5
相关论文
共 50 条
  • [41] NON-MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION TO TREAT HIGH RISK HEAVILY PRETREATED MULTIPLE
    Moreb, J. S.
    Wirk, B. M.
    Cogle, C.
    Jamieson, K. J.
    Hsu, J.
    Wingard, J. R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 69 - 70
  • [42] Tandem Autologous/Non-Myeloablative Allogeneic Transplantation for High Risk Non-Hodgkin Lymphoma (NHL)
    Fakhri, Bita
    Cashen, Amanda
    Comer, Holly
    Abboud, Camille
    Westervelt, Peter
    DiPersio, John E.
    Stockerl-Goldstein, Keith
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S300 - S300
  • [43] Non-myeloablative stem cell transplantation for the treatment of haematologic malignancies and metastatic solid tumours: a single-centre experience
    Cetin, M
    Altuntas, F
    Sari, I
    Eser, B
    Er, O
    Canoz, O
    Kaplan, B
    Ozkan, M
    Albayrak, E
    Bahar, S
    Ozkul, Y
    Patiroglu, T
    Unal, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S328 - S328
  • [44] NON MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION (NST) IN PATIENTS WITH HIGH RISK LYMPHOMA: A SINGLE CENTRE EXPERIENCE
    Console, G.
    Messina, G.
    Martino, M.
    Moscato, T.
    Fedele, R.
    Massara, E.
    Irrera, G.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S446 - S446
  • [45] Non myeloablative allogeneic stem cell transplantation (NST) in patients with high risk lymphoma:: A single centre experience
    Console, G.
    Moscato, T.
    Messina, G.
    Martino, M.
    Irrera, G.
    Pucci, G.
    Massara, E.
    Fedele, R.
    Cuzzola, M.
    Pontan, A.
    Callea, I
    Dattola, A.
    Condemi, A.
    Rigolino, C.
    Meliadò, A.
    Marcuccio, D.
    Gatto, F.
    Stelitano, C.
    Callea, V
    Mamone, D.
    Kropp, Mg
    Molica, S.
    Focarile, E.
    Pinto, A.
    Iacopino, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 202 - 202
  • [46] Tandem autologous plus non-myeloablative allogeneic stem cell transplantation in relapsed multiple myeloma: an Australian joint report from the Alfred and Myeloma and Related Diseases Registry
    Tedjaseputra, Aditya
    Das, Tongted
    Wellard, Cameron
    Spencer, Andrew
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S159 - S160
  • [47] Myeloablative allogeneic stem cell transplantation for advanced stage multiple myeloma: very long-term follow up of a single center experience
    Kennedy, G. A.
    Butler, J.
    Morton, J.
    Hill, G.
    Western, R.
    Cummings, J.
    Allison, R.
    Durrant, S.
    CLINICAL AND LABORATORY HAEMATOLOGY, 2006, 28 (03): : 189 - 197
  • [48] Excellent outcome of non-myeloablative stem cell transplant (NMSCT) for good risk myeloma: The EBMT experience.
    Lalancette, M
    Rezvani, K
    Szydlo, R
    Mackinnon, S
    Juliusson, G
    Michallet, M
    Slavin, S
    Frassoni, F
    Niederwieser, D
    Gahrton, G
    Apperley, J
    BLOOD, 2000, 96 (11) : 204A - 204A
  • [49] Long term follow-up in patient with high risk lymphoma underwent to non myeloablative allogeneic stem cell transplantation (NST): A single centre experience
    Console, Giuseppe
    Messina, Giuseppe
    Martino, Massimo
    Morabito, Fortunato
    Irrera, Giuseppe
    Pucci, Giulia
    Stelitano, Caterina
    Callea, Vincenzo
    Mamone, Domenico
    Kropp, Maria Grazia
    Molica, Stefano
    Abbadessa, Antonio
    Iacopino, Pasquale
    ANNALS OF ONCOLOGY, 2005, 16 : 62 - 62
  • [50] Incidence and prognostic significance of acute renal failure in myeloablative and non-myeloablative allogeneic stem cell transplant. single center experience
    Sitges, Marta
    Ferra, Christelle
    Soler, Jordi
    Morgades, Mireia
    Jose Jimenez, Maria
    Hernandez, Ines
    Torrent, Anna
    Pena, Marta
    Gener, Georgina
    Franch, Mireia
    Santos, Mireia
    Canamero, Eloi
    Comes, Martina
    Espasa, Andrea
    Batlle, Montserrat
    Moreno, Miriam
    Vives, Susana
    Manuel Sancho, Juan
    Xicoy, Blanca
    Oriol, Albert
    Abril, Laura
    Ibarra, Gladys
    Maria Ribera, Jose
    BONE MARROW TRANSPLANTATION, 2019, 54 : 274 - 274
12345